期刊文献+

临床治疗团队中临床药师应有的基本要素界定 被引量:8

Definition of Required Basic Elements of Clinical Pharmacists in Clinical Treatment Team
原文传递
导出
摘要 目的:界定临床治疗团队中临床药师应有的基本要素。方法:考察在临床中设定临床药师制度的目的、临床治疗团队中临床药师与临床医师的不同工作范畴以及不同专业要求等,从而界定出临床治疗团队中临床药师应有的基本要素。结果与结论:我国实行临床药师制度是医院临床制度建设的重大进步,而临床治疗团队中的临床药师必须具备其应有的临床责任、临床作用、临床能力和临床效果这四大临床应有的基本要素。只有这样,临床药师才能在临床治疗团队中成为不可替代的重要组成部分。 OBJECTIVE:To define the basic elements clinical pharmacists should possess in clinical treatment team.METHODS:The purpose of setting clinical pharmacists system was investigated.Different working scope and different professional requirements of clinical pharmacists and physicians were explored.The basic elements clinical pharmacists should possess in clinical treatment team were found out.RESULTSCONCLUSION:Clinical pharmacist system of our country is a significant progress of the hospital clinical system.Clinical pharmacists in the clinical treatment team must have four basic elements:clinical responsibility,clinical action,clinical ability and clinical effect.Only in this way,could clinical pharmacists in the clinical treatment team become an irreplaceable part.
作者 苏兰 唐尧
出处 《中国药房》 CAS CSCD 北大核心 2010年第30期2794-2795,共2页 China Pharmacy
关键词 临床药师 基本要素 治疗团队 Clinical pharmacists Basic element Treatment team
  • 相关文献

参考文献4

  • 1Bond C, Raehl C.Clinical pharmacy services, hospital pharmacy staffing, and medication errors in the United States hospitals [J].Pharmacotherapy, 2002,22 ( 2 ) : 134. 被引量:1
  • 2Jameson J, VanNoord G, Vanderwoud K.The impact of the pharma 2 cotherapy consultation on the cost and outcome of medical therapy[J]. J Family Practice, 1995, 41 (5) : 469. 被引量:1
  • 3Bond CA, Raehl CL, Pitterle ME, et al. Health care professional staffing, hospital characteristics, and hospital mortality rates [J]. Pharmacotherapy, 1999,19 (2) : 130. 被引量:1
  • 4Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in U. S. hospitals[J]. Pharmacotherapy, 2000,20 (6) : 609. 被引量:1

同被引文献65

  • 1卢熠,杨悦.美国临床药师开展药学服务的经验与启示[J].医药导报,2006,25(4):379-380. 被引量:37
  • 2张秀芝,杨敬荣,吴葆金,王尔华.氟罗沙星注射液的研制及其配伍变化分析[J].中国药科大学学报,1996,27(3):144-146. 被引量:15
  • 3王祥领.关于开展临床药学工作的几点思考[J].中国药房,2007,18(20):1596-1598. 被引量:10
  • 4Tully MP, Latif S, Cantrill JA, et al.Pharmacists' changing views of their supplementary prescribing authority[J]. Pharm World Sci , 2007,29(6) : 628. 被引量:1
  • 5Tonna AP, Stewart D, West B, et al.Pharmacist prescribing in the UK-a literature review of current practice and research[J].Journal of Clinical Pharmacy and Therapeutics, 2007,32(6) : 545. 被引量:1
  • 6Tonna AP. An international overview of some pharmacist prescribing models[J]Journal of the Malta College of Pharmacy Practice, 2008,14( 1 ) : 20. 被引量:1
  • 7Hoti K, Hughes J, Sunderland B. Pharmacy clients' atti- tudes to expanded pharmacist prescribing and the role of agency theory on involved stakeholders[J].lnternational Journal of Pharmacy Practice, 2011,19( 1 ) : 5. 被引量:1
  • 8Emmerton L, Marriott J, Bessell T, et al. Pharmacists and prescribing rights: Review of international developments [J].JPharm Pharmaceut Sci, 2005,8 (2) : 217. 被引量:1
  • 9Cooper RJ, Lymn J, Anderson C, et al.Learning to prescribe-pharmacists' experiences of supplementary pre- scribing training in England[J].BMC Medical Education, 2008,8(1) :57. 被引量:1
  • 10Hobson R, Sewell G. Risks and concerns about supplementary prescribing: Survey of primary and secondary care pharmacists[J].Pharm WorldSci, 2006,28(2) : 76. 被引量:1

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部